SARS-Cov-2 remains a continual threat to the population even after 2 years during which its molecular structure and its amino acid variations have been extensively documented . Although vaccines have been successfully developed and used, there still remains the development of a viable therapeutic that has no potential risk to the general individual. This is motivating in finding new small molecules, possibly unrelated to known molecules and without repurposing.